{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:11:49Z","timestamp":1793106709071,"version":"4.5.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Chem."],"abstract":"<jats:p>Coronaviruses infect a variety of hosts in the animal kingdom, and while each virus is taxonomically different, they all infect their host <jats:italic>via<\/jats:italic> the same mechanism. The coronavirus main protease (M<jats:sup>pro<\/jats:sup>, also called 3CL<jats:sup>pro<\/jats:sup>), is an attractive target for drug development due to its essential role in mediating viral replication and transcription. An M<jats:sup>pro<\/jats:sup> inhibitor, GC376, has been shown to treat feline infectious peritonitis (FIP), a fatal infection in cats caused by internal mutations in the feline enteric coronavirus (FECV). Recently, our lab demonstrated that the feline drug, GC373, and prodrug, GC376, are potent inhibitors of SARS-CoV-2 M<jats:sup>pro<\/jats:sup> and solved the structures in complex with the drugs; however, no crystal structures of the FIP virus (FIPV) M<jats:sup>pro<\/jats:sup> with the feline drugs have been published so far. Here, we present crystal structures of FIPV M<jats:sup>pro<\/jats:sup>-GC373\/GC376 complexes, revealing the inhibitors covalently bound to Cys144 in the active site, similar to SARS-CoV-2 M<jats:sup>pro<\/jats:sup>. Additionally, GC376 has a higher affinity for FIPV M<jats:sup>pro<\/jats:sup> with lower nanomolar K<jats:sub>i<\/jats:sub> values compared to SARS-CoV and SARS-CoV-2 M<jats:sup>pro<\/jats:sup>. We also show that improved derivatives of GC376 have higher potency for FIPV M<jats:sup>pro<\/jats:sup>. Since GC373 and GC376 represent strong starting points for structure-guided drug design, determining the crystal structures of FIPV M<jats:sup>pro<\/jats:sup> with these inhibitors are important steps in drug optimization and structure-based broad-spectrum antiviral drug discovery.<\/jats:p>","DOI":"10.3389\/fchem.2022.852210","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T06:56:15Z","timestamp":1645685775000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["Crystallization of Feline Coronavirus Mpro With GC376 Reveals Mechanism of Inhibition"],"prefix":"10.3389","volume":"10","author":[{"given":"Jimmy","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sizhu Amelia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Bashir","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raelynn","family":"Brassard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Arutyunova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tess","family":"Lamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard S.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Vederas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Joanne","family":"Lemieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus Main Proteinase (3CL Pro ) Structure: Basis for Design of Anti-SARS Drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science"},{"key":"B2","doi-asserted-by":"publisher","first-page":"167003","DOI":"10.1016\/j.jmb.2021.167003","article-title":"N-terminal Finger Stabilizes the S1 Pocket for the Reversible Feline Drug GC376 in the SARS-CoV-2 Mpro Dimer","volume":"433","author":"Arutyunova","year":"2021","journal-title":"J. Mol. Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.antiviral.2014.12.015","article-title":"The SARS-Coronavirus Papain-like Protease: Structure, Function and Inhibition by Designed Antiviral Compounds","volume":"115","author":"B\u00e1ez-Santos","year":"2015","journal-title":"Antiviral Res."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c00616","article-title":"Peptidomimetic \u03b1-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and In Vitro Biological Stability","author":"Bai","year":"2021","journal-title":"J. Med. Chem"},{"key":"B5","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/jmv.25681","article-title":"Emerging Coronaviruses: Genome Structure, Replication, and Pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J. Med. Virol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: Recent Insights into Emerging Coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1099\/vir.0.80985-0","article-title":"Genomic RNA Sequence of Feline Coronavirus Strain FIPV WSU-79\/1146","volume":"86","author":"Dye","year":"2005","journal-title":"J. Gen. Virol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3390\/v11111068","article-title":"Diagnosis of Feline Infectious Peritonitis: A Review of the Current Literature","volume":"11","author":"Felten","year":"2019","journal-title":"Viruses"},{"key":"B9","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ejmech.2018.03.004","article-title":"Structure-guided Design of Potent and Permeable Inhibitors of MERS Coronavirus 3CL Protease that Utilize a Piperidine Moiety as a Novel Design Element","volume":"150","author":"Galasiti Kankanamalage","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1099\/0022-1317-83-3-595","article-title":"Conservation of Substrate Specificities Among Coronavirus Main Proteases","volume":"83","author":"Hegyi","year":"2002","journal-title":"J. Gen. Virol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e1005650","DOI":"10.1371\/journal.ppat.1005650","article-title":"Correction: Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor","volume":"12","author":"Kim","year":"2016","journal-title":"Plos Pathog."},{"key":"B13","doi-asserted-by":"publisher","first-page":"11754","DOI":"10.1128\/jvi.01348-12","article-title":"Broad-Spectrum Antivirals against 3C or 3C-like Proteases of Picornaviruses, Noroviruses, and Coronaviruses","volume":"86","author":"Kim","year":"2012","journal-title":"J. Virol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.antiviral.2012.11.005","article-title":"Potent Inhibition of Feline Coronaviruses with Peptidyl Compounds Targeting Coronavirus 3C-like Protease","volume":"97","author":"Kim","year":"2013","journal-title":"Antiviral Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4942","DOI":"10.1128\/jvi.03688-14","article-title":"Broad-Spectrum Inhibitors against 3C-like Proteases of Feline Coronaviruses and Feline Caliciviruses","volume":"89","author":"Kim","year":"2015","journal-title":"J. Virol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19662-4","article-title":"Crystallographic Structure of Wild-type SARS-CoV-2 Main Protease Acyl-Enzyme Intermediate with Physiological C-Terminal Autoprocessing Site","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41422-020-0356-z","article-title":"Boceprevir, GC-376, and Calpain Inhibitors II, XII Inhibit SARS-CoV-2 Viral Replication by Targeting the Viral Main Protease","volume":"30","author":"Ma","year":"2020","journal-title":"Cell Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.tvjl.2014.04.016","article-title":"An Update on Feline Infectious Peritonitis: Diagnostics and Therapeutics","volume":"201","author":"Pedersen","year":"2014","journal-title":"Vet. J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1177\/1098612x17729626","article-title":"Efficacy of a 3C-like Protease Inhibitor in Treating Various Forms of Acquired Feline Infectious Peritonitis","volume":"20","author":"Pedersen","year":"2018","journal-title":"J. Feline Med. Surg."},{"key":"B20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.antiviral.2018.10.015","article-title":"Protease Inhibitors Broadly Effective against Feline, Ferret and Mink Coronaviruses","volume":"160","author":"Perera","year":"2018","journal-title":"Antiviral Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.1016\/j.bmcl.2015.10.023","article-title":"X-ray Structure and Inhibition of the Feline Infectious Peritonitis Virus 3C-like Protease: Structural Implications for Drug Design","volume":"25","author":"St. John","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B22","doi-asserted-by":"publisher","first-page":"108777","DOI":"10.1016\/j.vetmic.2020.108777","article-title":"Coronaviruses in Cats and Other Companion Animals: Where Does SARS-CoV-2\/covid-19 Fit?","volume":"247","author":"Stout","year":"2020","journal-title":"Vet. Microbiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1099\/vir.0.19424-0","article-title":"Mechanisms and Enzymes Involved in SARS Coronavirus Genome Expression","volume":"84","author":"Thiel","year":"2003","journal-title":"J. Gen. Virol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"5315","DOI":"10.1016\/j.bmcl.2011.07.016","article-title":"Design, Synthesis, and Evaluation of Inhibitors of Norwalk Virus 3C Protease","volume":"21","author":"Tiew","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B25","doi-asserted-by":"publisher","first-page":"113584","DOI":"10.1016\/j.ejmech.2021.113584","article-title":"Improved SARS-CoV-2 Mpro Inhibitors Based on Feline Antiviral Drug GC376: Structural Enhancements, Increased Solubility, and Micellar Studies","volume":"222","author":"Vuong","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1038\/s41467-020-18096-2","article-title":"Feline Coronavirus Drug Inhibits the Main Protease of SARS-CoV-2 and Blocks Virus Replication","volume":"11","author":"Vuong","year":"2020","journal-title":"Nat. Commun."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1128\/jvi.02685-15","article-title":"Crystal Structure of Feline Infectious Peritonitis Virus Main Protease in Complex with Synergetic Dual Inhibitors","volume":"90","author":"Wang","year":"2016","journal-title":"J. Virol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/v12020240","article-title":"Structural Basis for Inhibiting Porcine Epidemic Diarrhea Virus Replication with the 3C-like Protease Inhibitor GC376","volume":"12","author":"Ye","year":"2020","journal-title":"Viruses"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.jmb.2007.06.001","article-title":"A Mechanistic View of Enzyme Inhibition and Peptide Hydrolysis in the Active Site of the SARS-CoV 3C-like Peptidase","volume":"371","author":"Yin","year":"2007","journal-title":"J. Mol. Biol."}],"container-title":["Frontiers in Chemistry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2022.852210\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T06:56:18Z","timestamp":1645685778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2022.852210\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,24]]},"references-count":29,"alternative-id":["10.3389\/fchem.2022.852210"],"URL":"https:\/\/doi.org\/10.3389\/fchem.2022.852210","relation":{},"ISSN":["2296-2646"],"issn-type":[{"value":"2296-2646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,24]]},"article-number":"852210"}}